Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: Jul 30, 2019

Total Value: $2.397B (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 9.8%
Value $235M Shares 2,641,485 Share Price $88.83 * Est. Cost/Share $80.19 Unrealized @ Report Date +15.6%
INSM INSMED INC 9.3%
Value $222M Shares 7,653,617 Share Price $29.07 * Est. Cost/Share $16.83 Unrealized @ Report Date +54.0%
— ABIOMED INC 8.3%
Value $200M Shares 698,654 Share Price $285.59 Est. Cost/Share $35.35 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP DEL 8.0%
Value $192M Shares 1,632,025 Share Price $117.37 Est. Cost/Share $88.73 Unrealized @ Report Date +31.3%
— ALEXION PHARMACEUTICALS INC 6.9%
Value $166M Shares 1,229,030 Share Price $135.18 Est. Cost/Share $121.54 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 6.0%
Value $144M Shares 4,218,902 Share Price $34.19 * Est. Cost/Share $13.06 Unrealized @ Report Date +170.9%
— SAGE THERAPEUTICS INC 5.7%
Value $136M Shares 857,681 Share Price $159.05 Est. Cost/Share $48.62 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 5.4%
Value $130M Shares 5,239,304 Share Price $24.82 Est. Cost/Share $51.30 Unrealized @ Report Date —
— IMMUNOMEDICS INC 5.1%
Value $123M Shares 6,381,555 Share Price $19.21 Est. Cost/Share $13.36 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 4.3%
Value $104M Shares 7,619,833 Share Price $13.60 * Est. Cost/Share $7.42 Unrealized @ Report Date +64.6%
VNDA VANDA PHARMACEUTICALS INC 3.9%
Value $93.01M Shares 5,055,050 Share Price $18.40 * Est. Cost/Share $11.21 Unrealized @ Report Date +103.3%
— WRIGHT MED GROUP N V 3.6%
Value $87.16M Shares 2,771,394 Share Price $31.45 Est. Cost/Share $23.42 Unrealized @ Report Date —
— EPIZYME INC 3.6%
Value $85.93M Shares 6,935,074 Share Price $12.39 Est. Cost/Share $15.12 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 3.5%
Value $83.79M Shares 3,748,939 Share Price $22.35 Est. Cost/Share $22.88 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 2.5%
Value $60.37M Shares 2,248,403 Share Price $26.85 * Est. Cost/Share $27.39 Unrealized @ Report Date -14.7%
ALGN ALIGN TECHNOLOGY INC 2.0%
Value $47.03M Shares 165,405 Share Price $284.33 * Est. Cost/Share $114.31 Unrealized @ Report Date +108.8%
PBYI PUMA BIOTECHNOLOGY INC 1.9%
Value $45.8M Shares 1,180,780 Share Price $38.79 * Est. Cost/Share $30.02 Unrealized @ Report Date +1.7%
— AMAG PHARMACEUTICALS INC 1.8%
Value $44.07M Shares 3,421,306 Share Price $12.88 Est. Cost/Share $29.07 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 1.3%
Value $30.73M Shares 5,262,263 Share Price $5.84 Est. Cost/Share $17.42 Unrealized @ Report Date —
EXAS EXACT SCIENCES CORP 1.1%
Value $27.28M Shares 314,889 Share Price $86.62 Est. Cost/Share $13.61 Unrealized @ Report Date +525.3%
— MOMENTA PHARMACEUTICALS INC 1.1%
Value $26.76M Shares 1,841,613 Share Price $14.53 Est. Cost/Share $14.12 Unrealized @ Report Date —
— ALDER BIOPHARMACEUTICALS INC 1.1%
Value $25.41M Shares 1,861,630 Share Price $13.65 Est. Cost/Share $11.48 Unrealized @ Report Date —
— CELGENE CORP 1.0%
Value $25.13M Shares 266,333 Share Price $94.34 Est. Cost/Share $89.02 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 0.6%
Value $13.45M Shares 1,108,510 Share Price $12.13 * Est. Cost/Share $32.98 Unrealized @ Report Date -62.1%
KLDO KALEIDO BIOSCIENCES INC 0.5%
Value $12.57M Shares 866,666 Share Price $14.50 * Est. Cost/Share $13.76 Unrealized @ Report Date 0.0%
GILD GILEAD SCIENCES INC 0.5%
Value $11.44M Shares 175,900 Share Price $65.01 * Est. Cost/Share $62.02 Unrealized @ Report Date -18.0%
— RIGEL PHARMACEUTICALS INC 0.4%
Value $10.24M Shares 3,985,945 Share Price $2.57 Est. Cost/Share $3.40 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.3%
Value $7.338M Shares 500,913 Share Price $14.65 Est. Cost/Share $5.39 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.1%
Value $3.195M Shares 3,013,793 Share Price $1.06 Est. Cost/Share $4.88 Unrealized @ Report Date —
— ZOGENIX INC 0.1%
Value $1.623M Shares 29,500 Share Price $55.02 Est. Cost/Share $13.36 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.1%
Value $1.412M Shares 1,162,473 Share Price $1.21 Est. Cost/Share $4.37 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.0%
Value $1.001M Shares 123,686 Share Price $8.09 * Est. Cost/Share $6.71 Unrealized @ Report Date +9.5%
— MARINUS PHARMACEUTICALS INC 0.0%
Value $477K Shares 114,221 Share Price $4.18 Est. Cost/Share $4.18 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $245K Shares 247,000 Share Price $0.99 Est. Cost/Share $2.60 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.0%
Value $196K Shares 77,044 Share Price $2.54 Est. Cost/Share $8.90 Unrealized @ Report Date —
— MELINTA THERAPEUTICS INC 0.0%
Value $36,000 Shares 10,137 Share Price $3.55 Est. Cost/Share $3.55 Unrealized @ Report Date —
— HISTOGENICS CORP 0.0%
Value $35,000 Shares 302,922 Share Price $0.12 Est. Cost/Share $11.00 Unrealized @ Report Date —